Skip to main content
. 2024 Oct 18;14:24502. doi: 10.1038/s41598-024-74109-w

Fig. 8.

Fig. 8

Glioma patients with high CD9 expression may have a lower success rate of immunotherapy. (a) Immune checkpoints with different expression of CD9 in high and low expression groups (P value < 0.05); (b) Correlation between differential immune checkpoint and CD9; (c) TIDE fractions in high and low CD9 expression groups; Red indicates the CD9 high expression group, green indicates the CD9 low expression group.